Crossref journal-article
Elsevier BV
Journal of Controlled Release (78)
Bibliography

Lee, E., Kim, H., Lee, I.-H., & Jon, S. (2009). In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. Journal of Controlled Release, 140(2), 79–85.

Authors 4
  1. Eunhye Lee (first)
  2. Hyungjun Kim (additional)
  3. In-Hyun Lee (additional)
  4. Sangyong Jon (additional)
References 38 Referenced 125
  1. 10.1016/S0040-4020(01)81313-2 / Tetrahedron / Application of the vicinal oxymination reaction with asymmetric induction to the hemisynthesis of taxol and analogues by Mangatal (1989)
  2. 10.1023/A:1005740222307 / Cancer Metastasis Rev. / Molecular pathology of breast cancer and its application to clinical management by Walker (1997)
  3. 10.1021/np50067a001 / J. Nat. Prod. / The chemistry of taxol, a clinically useful anticancer agent by Kingston (1990)
  4. 10.1016/0163-7258(91)90004-6 / Pharmacol. Ther. / Effects of antimitotic agents on tubulin-nucleotide interactions by Correia (1991)
  5. 10.1016/S0140-6736(94)90754-4 / Lancet / The taxoids: paclitaxel and docetaxel by Gelmon (1994)
  6. 10.1097/01.cad.0000131685.06390.b7 / Anticancer Drugs / Non-allergic nature of docetaxel-induced acute hypersensitivity reactions by Ardavanis (2004)
  7. 10.2165/00003088-200342070-00005 / Clin. Pharmacokinet. / Pharmacological effects of formulation vehicles: implications for cancer chemotherapy by ten Tije (2003)
  8. 10.1023/A:1010618632738 / Invest. New Drugs / Role of formulation vehicles in taxane pharmacology by van Zuylen (2001)
  9. 10.1073/pnas.0601755103 / Proc. Natl. Acad. Sci. U.S.A. / Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo by Farokhzad (2006)
  10. 10.1016/j.jconrel.2005.12.013 / J. Control. Release / Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel by Kim (2006)
  11. 10.1016/j.biomaterials.2008.12.013 / Biomaterials / PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery by Chan (2009)
  12. 10.1016/j.jconrel.2008.02.003 / J. Control. Release / Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles by Hwang (2008)
  13. 10.1016/j.jconrel.2009.01.018 / J. Control. Release / Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles by Nam (2009)
  14. 10.1158/1078-0432.CCR-04-0118 / Clin. Cancer Res. / Fibrinogen-coated droplets of olive oil for delivery of docetaxel to a fibrin(ogen)-rich ascites from of a murine mammary tumor by Einhaus (2004)
  15. 10.1080/03639040802005057 / Drug Dev. Ind. Pharm. / Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel by Gao (2008)
  16. 10.1016/j.jconrel.2004.10.023 / J. Control. Release / Stable paclitaxel formulations in oily contrast medium by Lee (2005)
  17. 10.1158/1535-7163.MCT-07-0261 / Mol. Cancer Ther. / Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation by Hong (2007)
  18. 10.1016/S0168-3659(03)00271-2 / J. Control. Release / Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel by Immordino (2003)
  19. 10.1016/j.jconrel.2008.04.019 / J. Control. Release / Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes by Qiu (2008)
  20. 10.1002/cncr.11547 / Cancer / Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies by Fracasso (2003)
  21. 10.1002/jps.21599 / J. Pharm. Sci. / Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies by Esmaeili (2009)
  22. 10.1002/jps.21245 / J. Pharm. Sci. / Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel by Liu (2008)
  23. 10.1016/j.jconrel.2006.10.009 / J. Control. Release / Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992) by Sugahara (2007)
  24. 10.1021/bc060240p / Bioconjug. Chem. / Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel by Khandare (2006)
  25. 10.1158/1078-0432.CCR-07-2019 / Clin. Cancer Res. / A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity by Banzato (2008)
  26. 10.1200/JCO.1998.16.7.2557 / J. Clin. Oncol. / Oral chemotherapy: rationale and future directions by DeMario (1998)
  27. 10.1634/theoncologist.7-6-516 / Oncologist / Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview by Kruijtzer (2002)
  28. 10.1021/jm800767c / J. Med. Chem. / Conjugated chitosan as a novel platform for oral delivery of paclitaxel by Lee (2008)
  29. 10.1002/(SICI)1099-1263(199905/06)19:3<163::AID-JAT561>3.0.CO;2-H / J. Appl. Toxicol. / Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release by Arechabala (1999)
  30. 10.1006/abio.2000.4908 / Anal. Biochem. / A novel method of preparation of small intestinal brush border membrane vesicles by polyethylene glycol precipitation by Prabhu (2001)
  31. 10.1016/0005-2736(78)90440-6 / Biochim. Biophy. Acta. / A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes: their use in investigating some properties of d-glucose and choline transport systems by Kessler (1978)
  32. 10.1023/B:PHAM.0000012152.86004.aa / Pharm. Res. / Preparation and characterization of reconstructed small intestinal brush border membranes for surface plasmon resonance analysis by Cho (2004)
  33. 10.1023/B:PHAM.0000033011.56536.c3 / Pharm. Res. / Surface plasmon resonance studies of the direct interaction between a drug/intestinal brush border membrane by Kim (2004)
  34. 10.1016/0169-2607(96)01730-0 / Comput. Methods Programs Biomed. / Add-in macros for rapid and versatile calculation of non-compartmental pharmacokinetic parameters on Microsoft Excel spreadsheets by Sato (1996)
  35. 10.1021/bc049868v / Bioconjug. Chem. / Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure by Safavy (2004)
  36. {'key': '10.1016/j.jconrel.2009.08.014_bib36', 'first-page': '6158', 'article-title': 'Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir', 'volume': '62', 'author': 'Bardelmeijer', 'year': '2002', 'journal-title': 'Cancer Res.'} / Cancer Res. / Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir by Bardelmeijer (2002)
  37. 10.1016/j.biomaterials.2009.02.045 / Biomaterials / Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel by Feng (2009)
  38. 10.1016/S0090-4295(99)00451-3 / Urology / Taxanes: an overview of the pharmacokinetics and pharmacodynamics by Vaishampayan (1999)
Dates
Type When
Created 16 years ago (Aug. 27, 2009, 9:58 a.m.)
Deposited 6 years, 3 months ago (May 22, 2019, 2:52 a.m.)
Indexed 3 days, 9 hours ago (Sept. 4, 2025, 10:01 a.m.)
Issued 15 years, 9 months ago (Dec. 1, 2009)
Published 15 years, 9 months ago (Dec. 1, 2009)
Published Print 15 years, 9 months ago (Dec. 1, 2009)
Funders 0

None

@article{Lee_2009, title={In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration}, volume={140}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/j.jconrel.2009.08.014}, DOI={10.1016/j.jconrel.2009.08.014}, number={2}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Lee, Eunhye and Kim, Hyungjun and Lee, In-Hyun and Jon, Sangyong}, year={2009}, month=dec, pages={79–85} }